Cardiovascular drugs: Adenosine role in coronary syndromes and percutaneous coronary interventions

Oscar R. Rosales; Brian Eades; Abid R. Assali

doi:10.1002/ccd.20079

Cardiovascular drugs: Adenosine role in coronary syndromes and percutaneous coronary interventions

Oscar R. Rosales^*, Brian Eades, Abid R. Assali

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

14 Scopus citations

Abstract

Adenosine is an endogenous nucleoside available for the diagnosis and treatment of various cardiovascular conditions. It may be given for pharmacologic stress tests as well as administered directly into the coronary arteries during cardiac catheterization. The latter treatment may be utilized to measure fractional flow reserve in addition to treating the no-reflow phenomenon. Adenosine has also been shown to improve the clinical outcome of thrombolytics given in the setting of acute myocardial infarction. Adenosine is a useful agent for evaluation and treatment of the cardiovascular system.

Original language	English
Pages (from-to)	358-363
Number of pages	6
Journal	Catheterization and Cardiovascular Interventions
Volume	62
Issue number	3
DOIs	https://doi.org/10.1002/ccd.20079
State	Published - Jul 2004
Externally published	Yes

Keywords

AMI
AMISTAD trail
Acute myocardial infarction
Adenosine
No-reflow phenomenon
Noninvasive pharmacologic stress

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/ccd.20079

Cite this

@article{35c210a5b68d43538809bcd880e889ad,

title = "Cardiovascular drugs: Adenosine role in coronary syndromes and percutaneous coronary interventions",

abstract = "Adenosine is an endogenous nucleoside available for the diagnosis and treatment of various cardiovascular conditions. It may be given for pharmacologic stress tests as well as administered directly into the coronary arteries during cardiac catheterization. The latter treatment may be utilized to measure fractional flow reserve in addition to treating the no-reflow phenomenon. Adenosine has also been shown to improve the clinical outcome of thrombolytics given in the setting of acute myocardial infarction. Adenosine is a useful agent for evaluation and treatment of the cardiovascular system.",

keywords = "AMI, AMISTAD trail, Acute myocardial infarction, Adenosine, No-reflow phenomenon, Noninvasive pharmacologic stress",

author = "Rosales, {Oscar R.} and Brian Eades and Assali, {Abid R.}",

year = "2004",

month = jul,

doi = "10.1002/ccd.20079",

language = "אנגלית",

volume = "62",

pages = "358--363",

journal = "Catheterization and Cardiovascular Interventions",

issn = "1522-1946",

publisher = "John Wiley and Sons Inc.",

number = "3",

}

TY - JOUR

T1 - Cardiovascular drugs

T2 - Adenosine role in coronary syndromes and percutaneous coronary interventions

AU - Rosales, Oscar R.

AU - Eades, Brian

AU - Assali, Abid R.

PY - 2004/7

Y1 - 2004/7

N2 - Adenosine is an endogenous nucleoside available for the diagnosis and treatment of various cardiovascular conditions. It may be given for pharmacologic stress tests as well as administered directly into the coronary arteries during cardiac catheterization. The latter treatment may be utilized to measure fractional flow reserve in addition to treating the no-reflow phenomenon. Adenosine has also been shown to improve the clinical outcome of thrombolytics given in the setting of acute myocardial infarction. Adenosine is a useful agent for evaluation and treatment of the cardiovascular system.

AB - Adenosine is an endogenous nucleoside available for the diagnosis and treatment of various cardiovascular conditions. It may be given for pharmacologic stress tests as well as administered directly into the coronary arteries during cardiac catheterization. The latter treatment may be utilized to measure fractional flow reserve in addition to treating the no-reflow phenomenon. Adenosine has also been shown to improve the clinical outcome of thrombolytics given in the setting of acute myocardial infarction. Adenosine is a useful agent for evaluation and treatment of the cardiovascular system.

KW - AMI

KW - AMISTAD trail

KW - Acute myocardial infarction

KW - Adenosine

KW - No-reflow phenomenon

KW - Noninvasive pharmacologic stress

UR - http://www.scopus.com/inward/record.url?scp=3042702410&partnerID=8YFLogxK

U2 - 10.1002/ccd.20079

DO - 10.1002/ccd.20079

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 15224305

AN - SCOPUS:3042702410

SN - 1522-1946

VL - 62

SP - 358

EP - 363

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - 3

ER -

Cardiovascular drugs: Adenosine role in coronary syndromes and percutaneous coronary interventions

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this